Robert Andrew  Douglas net worth and biography

Robert Douglas Biography and Net Worth

Director of Globus Medical
Robert Douglas joined Globus Medical’s Board of Directors in December of 2019, and is a member of our Audit Committee. Mr. Douglas has nearly thirty years of experience in medical device technology, with particular expertise in digital health.  Currently, Mr. Douglas serves as the President and Chief Operating Officer in the Office of the CEO for ResMed Inc. (NYSE:RMD, ASX:RMD), a medical device and software applications company specializing in cloud-connected devices. ResMed’s solutions diagnose, treat and manage respiratory disorders and improve care in out-of-hospital settings. 

Mr. Douglas serves as Vice Chairman on the Board of Directors of the San Diego Regional Economic Development Corporation and is a member of its Executive Committee.  Mr. Douglas also serves as Vice Chairman on the Board of Directors of EvoNexus, a non-profit technology incubator and hub for Southern California’s startup community designed to accelerate the growth and success of entrepreneurial companies. 

Mr. Douglas has an M.B.A. from Macquarie University, a Bachelor’s degree in Electrical Engineering with first-class honors, and a B.S. in Computer Sciences from the University of New South Wales, Sydney.

What is Robert Andrew Douglas' net worth?

The estimated net worth of Robert Andrew Douglas is at least $21.22 million as of August 15th, 2023. Mr. Douglas owns 250,526 shares of Globus Medical stock worth more than $21,224,563 as of November 23rd. This net worth evaluation does not reflect any other assets that Mr. Douglas may own. Learn More about Robert Andrew Douglas' net worth.

How do I contact Robert Andrew Douglas?

The corporate mailing address for Mr. Douglas and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Robert Andrew Douglas' contact information.

Has Robert Andrew Douglas been buying or selling shares of Globus Medical?

Robert Andrew Douglas has not been actively trading shares of Globus Medical during the last quarter. Most recently, on Monday, August 24th, Robert Andrew Douglas bought 615 shares of Globus Medical stock. The stock was acquired at an average cost of $53.88 per share, with a total value of $33,136.20. Following the completion of the transaction, the director now directly owns 2,005 shares of the company's stock, valued at $108,029.40. Learn More on Robert Andrew Douglas' trading history.

Who are Globus Medical's active insiders?

Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.

Are insiders buying or selling shares of Globus Medical?

During the last year, insiders at the medical device company sold shares 8 times. They sold a total of 204,890 shares worth more than $14,523,237.10. The most recent insider tranaction occured on November, 6th when CEO Daniel T. Scavilla sold 60,000 shares worth more than $4,801,200.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.

Information on this page was last updated on 11/6/2024.

Robert Andrew Douglas Insider Trading History at Globus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/24/2020Buy615$53.88$33,136.202,005View SEC Filing Icon  
7/22/2020Buy690$47.75$32,947.501,390View SEC Filing Icon  
See Full Table

Robert Andrew Douglas Buying and Selling Activity at Globus Medical

This chart shows Robert Andrew Douglas's buying and selling at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globus Medical Company Overview

Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More

Today's Range

Now: $84.72
Low: $84.16
High: $85.30

50 Day Range

MA: $74.76
Low: $69.33
High: $84.97

2 Week Range

Now: $84.72
Low: $44.02
High: $85.30

Volume

966,796 shs

Average Volume

1,144,324 shs

Market Capitalization

$11.54 billion

P/E Ratio

126.45

Dividend Yield

N/A

Beta

1.17